Haleon plc, a leading global consumer healthcare company, is headquartered in Great Britain and operates extensively across Europe, North America, and Asia. Founded in 2022, Haleon emerged from a spin-off of GlaxoSmithKline's consumer healthcare division, marking a significant milestone in the industry. Specialising in over-the-counter medicines, oral health, and wellness products, Haleon offers a diverse portfolio that includes well-known brands such as Sensodyne, Panadol, and Voltaren. These products are distinguished by their commitment to science-backed efficacy and consumer trust. With a strong market position, Haleon is dedicated to improving everyday health and well-being, making it a notable player in the consumer healthcare sector. The company's focus on innovation and sustainability further enhances its reputation as a forward-thinking leader in the industry.
How does Haleon plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Haleon plc's score of 85 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Haleon plc reported significant carbon emissions, totalling approximately 2,529,000,000 kg CO2e across all scopes. This includes 68,000,000 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 7,000,000 kg CO2e from Scope 2 emissions (market-based). The company’s Scope 3 emissions were notably high, accounting for about 2,529,000,000 kg CO2e, with the largest contributions from purchased goods and services (approximately 1,498,000,000 kg CO2e) and use of sold products (426,000,000 kg CO2e). Haleon has set ambitious climate commitments, aiming to achieve net zero carbon emissions across all scopes by 2040. Specifically, the company targets a 100% reduction in net Scope 1 and 2 emissions by 2030, using a 2020 baseline. Additionally, it aims to reduce Scope 3 emissions by 42% by 2030 compared to a 2022 baseline. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Haleon's commitment to sustainable practices in the consumer durables sector. In the UK, Haleon reported Scope 1 emissions of 2,000,000 kg CO2e and Scope 2 emissions of 3,000,000 kg CO2e for 2024, contributing to a total of 5,000,000 kg CO2e for Scope 1 and 2 combined. The company is on track to meet its near-term targets, which include a 95% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2020 baseline. Overall, Haleon plc is actively working towards substantial emissions reductions and has committed to long-term sustainability goals, demonstrating leadership in addressing climate change within its industry.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Scope 1 | 59,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 37,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haleon plc is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.